Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Regencell Bioscience Holdings Limited

Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering
From Regencell Bioscience Holdings Limited
Via Business Wire
Tickers RGC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.